Literature DB >> 18692069

Stability and ATP binding of the nucleotide-binding domain of the Wilson disease protein: effect of the common H1069Q mutation.

Agustina Rodriguez-Granillo1, Erik Sedlak, Pernilla Wittung-Stafshede.   

Abstract

Perturbation of the human copper-transporter Wilson disease protein (ATP7B) causes intracellular copper accumulation and severe pathology, known as Wilson disease (WD). Several WD mutations are clustered within the nucleotide-binding subdomain (N-domain), including the most common mutation, H1069Q. To gain insight into the biophysical behavior of the N-domain under normal and disease conditions, we have characterized wild-type and H1069Q recombinant N-domains in vitro and in silico. The mutant has only twofold lower ATP affinity compared to that of the wild-type N-domain. Both proteins unfold in an apparent two-state reaction at 20 degrees C and ATP stabilizes the folded state. The thermal unfolding reactions are irreversible and, for the same scan rate, the wild-type protein is more resistant to perturbation than the mutant. For both proteins, ATP increases the activation barrier towards thermal denaturation. Molecular dynamics simulations identify specific differences in both ATP orientation and protein structure that can explain the absence of catalytic activity for the mutant N-domain. Taken together, our results provide biophysical characteristics that may be general to N-domains in other P(1B)-ATPases as well as identify changes that may be responsible for the H1069Q WD phenotype in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692069     DOI: 10.1016/j.jmb.2008.07.065

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Exhaustive search and solvated interaction energy (SIE) for virtual screening and affinity prediction.

Authors:  Traian Sulea; Hervé Hogues; Enrico O Purisima
Journal:  J Comput Aided Mol Des       Date:  2011-12-25       Impact factor: 3.686

2.  Nucleotide recognition by CopA, a Cu+-transporting P-type ATPase.

Authors:  Takeo Tsuda; Chikashi Toyoshima
Journal:  EMBO J       Date:  2009-05-28       Impact factor: 11.598

Review 3.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

Review 4.  The Present and Future Challenges of Wilson's Disease Diagnosis and Treatment.

Authors:  Marcia Leung; Paul B Aronowitz; Valentina Medici
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

5.  Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.

Authors:  Oleg Y Dmitriev; Ashima Bhattacharjee; Sergiy Nokhrin; Eva-Maria E Uhlemann; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2011-03-11       Impact factor: 5.157

Review 6.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

Review 7.  Modifying factors and phenotypic diversity in Wilson's disease.

Authors:  Svetlana Lutsenko
Journal:  Ann N Y Acad Sci       Date:  2014-04-04       Impact factor: 5.691

8.  Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease.

Authors:  Rosanna Squitti; Renato Polimanti; Serena Bucossi; Mariacarla Ventriglia; Stefania Mariani; Dario Manfellotto; Fabrizio Vernieri; Emanuele Cassetta; Francesca Ursini; Paolo Maria Rossini
Journal:  Rejuvenation Res       Date:  2013-02       Impact factor: 4.663

9.  Elucidation of the ATP7B N-domain Mg2+-ATP coordination site and its allosteric regulation.

Authors:  Claude Hercend; Cyril Bauvais; Guillaume Bollot; Nicolas Delacotte; Philippe Chappuis; France Woimant; Jean-Marie Launay; Philippe Manivet
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

10.  The uncoupled ATPase activity of the ABC transporter BtuC2D2 leads to a hysteretic conformational change, conformational memory, and improved activity.

Authors:  Nurit Livnat-Levanon; Amy I Gilson; Nir Ben-Tal; Oded Lewinson
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.